References

---

Arnon, S., Schechter, R., Inglesby, T. et al. (2001). Botulinum Toxin as a Biological Weapon. Journal of the American Medical Association. 285, (8): 1059-1070.

Agency for Toxic Substance and Disease Registry (ATSDR). (2001)
http://www.bt.cdc.gov/agent/nerve/Nervesfnl.pdf

CDC. (1998) Bioterrorism Alleging Use of Inhalation Anthrax and Interim Guidelines for Management –
United States. MMWR Morbidity-Mortality Weekly Report. 48: 4

CDC. (1997) Human Exposure to Brucella abortus Strain RB51 – Kansas. MMWR. 47: 172-174.

CDC. (2001) International Chemical Safety Cards. http://www.bt.cdc.gov/

Dennis, D., Inglesby, T., Henderson, D. et al (2001). Tularemia as a Biological Weapon: Medical and public
health management. Journal of the American Medical Association. 285, (21), 2763-2773

Henderson, D., Inglesby, T., Bartlett, J. (1999). Smallpox as a Biological Weapon: Medical and public health
management. Journal of the American Medical Association. 281, (22), 2127-2137.

Inglesby, T., Henderson, D., Bartlett, J., et al (1999). Anthrax as a Biological Weapon: Medical and public
health management. Journal of the American Medical Association. 281, (18): 1735-1745

Inglesby, T., Dennis, D., Henderson, D., et al. (2000). Plague as a Biological Weapon: Medical and public
health management. Journal of the American Medical Association. 283, (17): 2281 - 2289

Rebmann, T. (2001). What Infection Control Practitioners Need to Know to be Prepared to a
Bioterrorism Attack. Infection Control Today. 5, (12):24 – 27.

Smego, R., Gebrian, B., Desmangels, G. (1998). Cutaneous Manifestations of Anthrax in Rural Haiti.
Clinical Infectious Diseases. 26, 97-102.